Pharmaceutical Preparations · DE · CIK 1446847
Develops and commercializes life-changing therapies for gastrointestinal and rare diseases
Comparable business profile · signals at a glance
In the 90 days to Mar 17, 2026: 7 sold $21.9M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 17, 2026 | Denner Alexander JDirector | Sell | 6,725,000 | $3.05 | $20.5M |
| Mar 17, 2026 | Denner Alexander JDirector | Sell | 5,800 | $3.31 | $19K |
| Feb 24, 2026 | Mccourt Thomas AChief Executive Officer | Sell | 103,526 | $3.66 | $379K |
| Feb 24, 2026 | John MinardoChief Legal Officer | Sell | 19,053 | $3.66 | $70K |
| Feb 24, 2026 | Shetzline MichaelSVP, CMO, Head-Res&Drug | Sell | 17,012 | $3.66 | $62K |
| Feb 24, 2026 | Silver RonaldPrincipal Accounting Officer | Sell | 12,621 | $3.66 | $46K |
| Feb 24, 2026 | Martini Gregory S.Chief Financial Officer | Sell | 11,457 | $3.66 | $42K |
| Feb 24, 2026 | Gaskins Tammi LChief Commercial Officer | Sell | 11,239 | $3.66 | $41K |
| Feb 23, 2026 | Mccourt Thomas AChief Executive Officer | Sell | 94,757 | $3.81 | $361K |
| Feb 23, 2026 | John MinardoChief Legal Officer | Sell | 17,439 | $3.81 | $66K |
| Feb 23, 2026 | Shetzline MichaelSVP, CMO, Head-Res&Drug | Sell | 15,570 | $3.81 | $59K |
| Feb 23, 2026 | Silver RonaldPrincipal Accounting Officer | Sell | 11,552 | $3.81 | $44K |
| Feb 23, 2026 | Martini Gregory S.Chief Financial Officer | Sell | 10,487 | $3.81 | $40K |
| Feb 23, 2026 | Gaskins Tammi LChief Commercial Officer | Sell | 10,287 | $3.81 | $39K |
| Jan 5, 2026 | Silver RonaldPrincipal Accounting Officer | Sell | 35,416 | $4.60 | $163K |
| Nov 17, 2025 | Gaskins Tammi LChief Commercial Officer | Sell | 6,016 | $3.32 | $20K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.